Can a 58-year-old male be prescribed Adderall (mixed amphetamine salts) for ADHD or narcolepsy, and what are the appropriate starting dose, titration schedule, and monitoring parameters?

Can Adderall Be Prescribed to a 58-Year-Old Male?

Yes, Adderall (mixed amphetamine salts) can be prescribed to a 58-year-old male for ADHD or narcolepsy, with appropriate cardiovascular screening and monitoring. The FDA label explicitly approves Adderall for both ADHD and narcolepsy in adults without age restrictions 1.

Key Indications

Adderall is FDA-approved for:

• ADHD (all subtypes, including combined, inattentive, and hyperactive-impulsive types) 1
• Narcolepsy 1

The 2002 AACAP practice parameter confirms that adults with ADHD benefit from stimulant treatment, noting that ADHD symptoms persist into adult life and cause significant impairment in job stability, relationships, and daily functioning 2.

Starting Dose and Titration

For ADHD:

• Start with 5 mg once or twice daily 2, 1
• Titrate upward in 5-10 mg increments weekly until symptoms are controlled 2
• Maximum daily dose typically 40-60 mg/day (PDR states 40 mg for amphetamines, though clinical practice may reach 60-65 mg in adults with documented need) 2
• Give first dose upon awakening; additional doses at 4-6 hour intervals 1

For Narcolepsy:

• Start with 10 mg daily in adults 1
• Titrate in 10 mg increments weekly until optimal response 1
• Usual dose range: 5-60 mg/day in divided doses 1

Critical point: Adults may require higher total daily doses than children because they need coverage across a longer waking day, with some patients treated up to 1.0 mg/kg of methylphenidate or 0.9 mg/kg of amphetamines 2.

Mandatory Pre-Treatment Cardiovascular Assessment

Before prescribing, you must assess for cardiac disease 1:

• Detailed personal cardiac history
• Family history of sudden death or ventricular arrhythmia
• Physical examination with vital signs
• Baseline ECG (recommended given age)
• Blood pressure measurement

This is non-negotiable given that Adderall is a Schedule II controlled substance with sympathomimetic effects 1.

Monitoring Parameters

Initial Titration Phase (2-4 weeks):

• Weekly contact (office visit or phone) 2
• ADHD symptom ratings from patient and significant other 2
• Systematic side effect assessment at each contact: insomnia, anorexia, headaches, agitation, cardiovascular symptoms 2
• Blood pressure and pulse at each visit 2

Maintenance Phase:

• Monthly visits minimum until symptoms stabilized 2
• Blood pressure, pulse, and weight at each visit 2
• Periodic ECG monitoring (especially in older adults)
• Screen for tolerance, abuse potential, and mood changes 2

Long-term data from 223 adults treated up to 24 months showed mean increases in DBP of 1.3 mm Hg, SBP of 2.3 mm Hg, and pulse of 2.1 bpm—small and not clinically significant in otherwise healthy adults 3. However, 5 subjects discontinued due to hypertension in this cohort 3.

Contraindications and Red Flags

Absolute contraindications (from FDA label and guidelines):

• Advanced arteriosclerosis
• Symptomatic cardiovascular disease
• Moderate to severe hypertension
• Hyperthyroidism
• Known hypersensitivity to amphetamines
• Glaucoma
• Agitated states
• History of drug abuse (relative contraindication requiring careful assessment) 2
• During or within 14 days of MAOI use

Special consideration for age 58: While not a contraindication, this age group has higher baseline cardiovascular risk. The evidence shows stimulants can be used safely with appropriate monitoring 4, 3, but you must be more vigilant about blood pressure and cardiac symptoms.

Evidence Quality and Clinical Considerations

The strongest evidence comes from:

• FDA drug label 1 providing clear dosing and indications
• 2002 AACAP guidelines [2-2] establishing adult ADHD treatment protocols
• Multiple RCTs in adults demonstrating efficacy with effect sizes of 0.8 and 12-hour symptom control 5

Recent 2022 data confirms amphetamine extended-release remains effective in adults with anticipated safety profiles 6. A 2025 network meta-analysis found amphetamines show efficacy plateaus above approximately 50 mg/day in adults, with dose-dependent increases in discontinuation due to adverse events above this threshold 7.

Common Pitfalls to Avoid

1. Don't undertitrate: Many clinicians stop at subtherapeutic doses. Adults often need 40-60 mg/day for optimal response 2, 5

2. Don't skip cardiovascular screening: This is the most critical safety step in older adults

3. Don't ignore comorbid substance use: Obtain detailed drug/alcohol history and consider urine drug screen 2

4. Don't forget to assess for bipolar disorder: Stimulants can precipitate mania; rule out bipolar disorder before initiating treatment 2

5. Don't prescribe without confirming childhood onset: ADHD diagnosis requires symptoms present before age 7 (DSM-IV criteria used in guidelines) or age 12 (DSM-5) 2, 1

Hypertension Consideration

If your 58-year-old patient has controlled hypertension on antihypertensives, Adderall can still be used safely. An open-label study of 13 adults with ADHD and treated essential hypertension showed no sustained blood pressure elevation or clinically significant ECG changes when treated with MAS XR up to 60 mg/day 4. However, monitor blood pressure at every visit and maintain close communication with the patient's cardiologist or primary care physician.

Bottom line for this patient: Start 5 mg once or twice daily, titrate by 5-10 mg weekly based on response and tolerability, monitor cardiovascular parameters closely given age, and expect to reach 40-60 mg/day for optimal ADHD control or 10-60 mg/day for narcolepsy.